Q2 2025 Chemed Corp Earnings Call Transcript
Key Points
- VITAS net revenue increased by 5.8% in the second quarter of 2025 compared to the prior year, driven by a 6.1% increase in days of care and a 4.2% increase in Medicare reimbursement rates.
- Hospital-directed admissions at VITAS increased by 9.1%, indicating a strategic focus on short-stay patients to mitigate Medicare cap issues.
- Roto-Rooter branch commercial revenue increased by 4.4%, driven by significant growth in excavation and water restoration services.
- Chemed Corp (CHE) is actively managing its patient mix in Florida to address Medicare cap issues, with expectations of no significant cap limitations in 2026.
- The company is confident in the long-term growth potential and strategic direction of both VITAS and Roto-Rooter, despite short-term challenges.
- Both operating units, VITAS and Roto-Rooter, did not meet internal expectations for the second quarter of 2025.
- Homebase patient admissions at VITAS declined by 6.2%, with nursing home and assisted living facilities admissions also decreasing.
- Roto-Rooter revenue growth was only 0.6% in the second quarter of 2025, falling short of internal expectations.
- The company faced a $16.4 million Medicare Cap billing limitation in the second quarter, impacting revenue growth.
- Roto-Rooter's adjusted EBITDA decreased by 18.7% compared to the prior year, with a significant decline in EBITDA margin due to inefficiencies and higher costs.
Hello, and welcome to Chemed Corporation's second quarter 2025 earnings conference call. (Operator Instructions)
I would now like to turn the conference over to Holley Schmidt. You may begin.
Good morning. Our conference call this morning will review the financial results for the second quarter of 2025 ended June 30, 2025.
Before we begin, let me remind you that the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995 apply to this conference call. During the course of this call, the company will make various remarks concerning management's expectations, predictions, plans and prospects that constitute forward-looking statements.
Actual results may differ materially from those projected by these forward-looking statements as a result of a variety of factors, including those identified in the company's news release of July 29 and in various other filings with the SEC. You are cautioned that any forward-looking statements reflect management
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
